Autoinjector Market Size Projected to Reach $37 billion by 2034 | 14.4%

According to Straits Research the global autoinjectors market size was valued at $10.18 billion in 2025 and is expected to grow from $11.52 billion in 2026 to $31.45 billion by 2034, registering a CAGR of 13.37% during the forecast period 2026–2034.

Straits Research, a leading market research organization, announced the release of the report titled "Autoinjectors Market Size and Outlook—Forecasts till 2034." The report provides an in-depth analysis of the market size, trends, opportunities, and market mechanism. The report also covers a regional analysis of several market factors.

 

The autoinjectors market is segmented based on product type, indication, and region. Some of the insights provided in the report are highlighted below:

• The reusable autoinjectors segment is expected to be the fastest-growing segment, projected to have a CAGR of 14.4% during the forecast period.
• North America is expected to lead the market during the forecast period, owing to increasing R&D investments in drug delivery technologies for user-friendly designs.
• Autoinjectors are increasingly being integrated with mobile health applications since they improve medication tracking and management.
• Brazil is the leading autoinjectors market in Latin America, supported by an expanding diabetic population and increasing collaborations between local and global pharmaceutical companies.

Straits Research adopts a rigorous 360° research approach that integrates both primary and secondary research methodologies. The report data is triangulated with a mix of market indicators, macroeconomic outlook, industry sources, and strategic briefings.

The report is designed to enable decision makers, such as CXOs, policymakers, investors, startups, and other related stakeholders, to understand the current and future scenario of the market. 

Market Segments

By Product Type

• Disposable Autoinjectors
• Reusable Autoinjectors

By Indication

• Rheumatoid Arthritis
• Multiple Sclerosis
• Diabetes
• Anaphylaxis

By Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

For queries related to custom and related reports, please speak to our analyst.